Cargando…
Targeting Post-Translational Modifications of the p73 Protein: A Promising Therapeutic Strategy for Tumors
SIMPLE SUMMARY: The tumor suppressor TAp73 is a member of the p53 family, which is inhibited in many human solid and hematological tumors. In contrast to those in the p53 gene, mutations in the p73 gene are very rare in tumors, suggesting that the decrease in TAp73 activity and expression detected i...
Autores principales: | Omran, Ziad, H. Dalhat, Mahmood, Abdullah, Omeima, Kaleem, Mohammed, Hosawi, Salman, A Al-Abbasi, Fahd, Wu, Wei, Choudhry, Hani, Alhosin, Mahmoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071514/ https://www.ncbi.nlm.nih.gov/pubmed/33921128 http://dx.doi.org/10.3390/cancers13081916 |
Ejemplares similares
-
Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex
por: Abdullah, Omeima, et al.
Publicado: (2021) -
The Potential Role of Nigella sativa Seed Oil as Epigenetic Therapy of Cancer
por: Alsanosi, Safialdin, et al.
Publicado: (2022) -
HAUSP Is a Key Epigenetic Regulator of the Chromatin Effector Proteins
por: Abdullah, Omeima, et al.
Publicado: (2021) -
Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy
por: Choudhry, Hani, et al.
Publicado: (2018) -
Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer
por: Alhosin, Mahmoud, et al.
Publicado: (2016)